0.3123

5.28% -0.0174

Collplant Biotechnologies Ltd (CLGN)

Overview News Price History Option Chain Discussions Forecast

Collplant Biotechnologies Ltd stock is traded at $0.3123, with a volume of 13,878. It is down -5.28% in the last 24 hours and down -6.78% over the past month. CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Previous Close:

$0.3297

Open:

$0.3003

24h Volume:

13,878

Relative Volume:

0.24

Market Cap:

$6.04M

Revenue:

$389.00K

Net Income/Loss:

$-13.13M

P/E Ratio:

-0.3025

EPS:

-1.0323

Net Cash Flow:

$-11.90M

1W Performance:

-3.88%

1M Performance:

-6.78%

6M Performance:

-50.74%

1Y Performance:

-87.75%

1-Day Range:

$0.2955

$0.3197

1-Week Range:

$0.29

$0.3394

52-Week Range:

$0.2699

$3.18

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name

Collplant Biotechnologies Ltd

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

Address

Employee

Twitter

@CollplantBio

Next Earnings Date

2026-08-19

Latest SEC Filings

CLGN's Discussions on Twitter

Compare CLGN vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLGN Collplant Biotechnologies Ltd	0.3195	6.23M	389.00K	-13.13M	-11.90M	-1.0323
VRTX Vertex Pharmaceuticals Inc	515.90	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.46	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.29	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	213.97	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.63	39.31B	5.76B	514.49M	1.10B	4.4813

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-17-23	Initiated	Alliance Global Partners	Buy

Collplant Biotechnologies Ltd Stock (CLGN) Latest News

Aug 06, 2026

CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks

Aug 06, 2026

CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan

Aug 06, 2026

Jul 31, 2026

Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan

Jul 31, 2026

Jul 30, 2026

CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - The Globe and Mail

Jul 30, 2026

Jul 29, 2026

CollPlant Biotechnologies (CLGN) investors approve EGM proposal - Stock Titan

Jul 29, 2026

Jul 28, 2026

CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan

Jul 28, 2026

Jul 27, 2026

CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan

Jul 27, 2026